Contact
 

CAPRISA 004 in Science and iPrEx in New England Journal of Medicine shortlisted for Lancet paper of the year

The CAPRISA 004 study of tenofovir gel for women published in Science in July and the iPrEx study of pre-exposure prophylaxis for men who have sex with men published in the New England Journal of Medicine in November are among 6 papers shortlisted for the Lancet paper of the year (see attached). You can have a say in whether one of them gets to the top of the pile or not. You can vote before January 31 for the paper of the year at http://www.surveymonkey.com/s/POY2010

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account